Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September

Inovio Pharmaceuticals Inc expects its experimental COVID19 vaccine to enter midtolate stage study in September and secure U.S. emergency use authorization sometime in 2021, the U.S. vaccine developer said on Monday.

from Top Business News- News18.com https://ift.tt/3abdvqo

• Tweet
• Share
• Share
• Share
• Share